Related Experiment Videos
Improved blood pressure control by monitoring compliance with antihypertensive therapy
B Waeber1, W Vetter, R Darioli
1Division of Hypertension and Vascular Medicine, CHUV, Lausanne, Switzerland.
Insights
Monitoring medication adherence in hypertensive patients for three months significantly improved blood pressure control. Discussing adherence and using electronic dispensers can enhance patient outcomes in managing hypertension.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Pharmacy
Background:
- Hypertension management requires consistent adherence to prescribed medication.
- Suboptimal adherence to antihypertensive therapy is a common challenge in clinical practice.
- Electronic monitoring offers a method to objectively assess medication compliance.
Purpose of the Study:
- To evaluate the impact of monitoring antihypertensive therapy compliance on blood pressure control.
- To assess the effectiveness of electronic medication dispensers in tracking adherence.
- To determine if improved compliance correlates with better blood pressure outcomes.
Main Methods:
- A three-month prospective study involving 35 hypertensive patients.
- Utilized an electronic medication dispenser to monitor daily drug intake.
- Blood pressure and compliance rates were recorded throughout the study period.
Main Results:
- Significant reduction in mean blood pressure from 167.9/100.4 mmHg to 152.5/90.9 mmHg (p < 0.001).
- Average daily opening rate of the dispenser was 80.8%.
- The observed blood pressure decrease was attributed to likely increased medication compliance.
Conclusions:
- Discussing adherence and monitoring compliance using electronic dispensers improves blood pressure control in hypertensive patients.
- Objective compliance monitoring can identify adherence issues and guide therapeutic interventions.
- Enhanced adherence to antihypertensive medication is crucial for effective hypertension management.
Abstract:
Compliance with antihypertensive therapy was monitored for three months using an electronic medication dispenser in 35 patients remaining hypertensive despite the once-daily administration of a blood pressure lowering drug (either as monotherapy or as fixed-dose combination therapy). During the monitoring of compliance, the treatment was unchanged but blood pressure decreased significantly (p < 0.001) from 167.9/100.4 +/- 16.3/7.2 mmHg (mean +/- SD) to 152.5/90.9 +/- 20.9/11.5 mmHg. The percentage of days with one opening per day was 80.8 +/- 20.5. Thus, discussing with the patient about compliance with the prescribed drug regimen and monitoring compliance for a few months allows better control of blood pressure. This most likely reflects increased compliance with antihypertensive drug therapy.